Our Medicines
Drug Promotional Information
Incyte Biosciences France undertakes to respect the principles of the information charter by canvassing or prospecting aimed at the promotion of medicinal products. The Charter in force is accessible here.
The requirements of this charter are translated into auditable criteria in a certification reference system for information activity by canvassing or prospecting aimed at promoting medicines, established by the HAS (version in force from March 2017).
As part of this procedure, Incyte Biosciences France has been certified for its promotional information activity by the AFAQ AFNOR organization since December 7, 2015.
Incyte Biosciences France is involved in a process of continuous improvement of the quality of promotional information, deployed from a quality policy validated by management. Incyte's three commitments are:
- Ensuring patient safety
- Provide reliable, quality and up-to-date information on the proper use of products to healthcare professionals
- Comply with the rules of ethics set out in the charter
Pemazyre® (pemigatinib)
Minjuvi® (tafasitamab)